Baohua Dongnuo Biotechnology BHD
Retatrutide
Finnrick tested 6 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Baohua Dongnuo Biotechnology BHD between 11 Aug 2025 and 22 Feb 2026. Test scores average over 6, no score below 5, and at least 6 tests warrant a confident Finnrick Rating of B (Good).
Finnrick Rating™
Baohua Dongnuo Biotechnology BHD
Retatrutide
Tested 6 Samples
Last test 22 Feb 2026
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Baohua Dongnuo Biotechnology BHD
Samples are tested in commercial labs
Tests Count
6
Scores
AVGMINMAX
Last
22 Feb 2026
First
11 Aug 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 22 Feb 2026 | View | 20mg | 22.1mg | +10.5% | 99.90% | (no batch ID) | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 19 Jan 2026 | View | 19.94mg | 20.5mg | +2.8% | 99.95% | (no batch ID) | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 19 Jan 2026 | View | 10mg | 10.3mg | +3.0% | 98.17% | (no batch ID) | No Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 4 Sep 2025 | View | 10mg | 9.43mg | -5.7% | 99.94% | (no batch ID) | No Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 1 Sep 2025 | View | 30mg | 30.44mg | +1.5% | 99.85% | (no batch ID) | No Label / Silver Crimp / Pink Cap | Lab F | Public | |
| 11 Aug 2025 | View | 20mg | 19.3mg | -3.5% | 99.95% | (no batch ID) | No Label / Silver Crimp / Violet Cap | Lab E | Public | |